- Home
- SSKN vs SNSE Comparison
SSKN vs SNSE Comparison
Compare SSKN & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- SNSE
- Stock Information
- Founded
- SSKN 1989
- SNSE 2005
- Country
- SSKN United States
- SNSE United States
- Employees
- SSKN N/A
- SNSE N/A
- Industry
- SSKN Medical/Dental Instruments
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- SNSE Health Care
- Exchange
- SSKN Nasdaq
- SNSE Nasdaq
- Market Cap
- SSKN 9.7M
- SNSE 10.8M
- IPO Year
- SSKN 2005
- SNSE 2021
- Fundamental
- Price
- SSKN $2.36
- SNSE $7.95
- Analyst Decision
- SSKN Strong Buy
- SNSE Strong Buy
- Analyst Count
- SSKN 1
- SNSE 3
- Target Price
- SSKN $6.00
- SNSE $86.67
- AVG Volume (30 Days)
- SSKN 18.6K
- SNSE 13.2K
- Earning Date
- SSKN 08-13-2025
- SNSE 08-05-2025
- Dividend Yield
- SSKN N/A
- SNSE N/A
- EPS Growth
- SSKN N/A
- SNSE N/A
- EPS
- SSKN N/A
- SNSE N/A
- Revenue
- SSKN $33,620,000.00
- SNSE N/A
- Revenue This Year
- SSKN $3.31
- SNSE N/A
- Revenue Next Year
- SSKN $9.67
- SNSE N/A
- P/E Ratio
- SSKN N/A
- SNSE N/A
- Revenue Growth
- SSKN 3.30
- SNSE N/A
- 52 Week Low
- SSKN $2.10
- SNSE $5.00
- 52 Week High
- SSKN $3.80
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- SSKN 48.71
- SNSE 49.64
- Support Level
- SSKN $2.34
- SNSE $8.76
- Resistance Level
- SSKN $2.53
- SNSE $9.27
- Average True Range (ATR)
- SSKN 0.21
- SNSE 0.46
- MACD
- SSKN 0.01
- SNSE -0.07
- Stochastic Oscillator
- SSKN 23.19
- SNSE 27.35
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).